Bill
HB 21
Delaware regulates or prohibits tianeptine sales, an uncontrolled substance increasingly sold as a dietary supplement with abuse and withdrawal risks.
HB 21 amends Delaware's Title 16 (Health and Safety Code) to regulate tianeptine, a substance increasingly sold as a dietary supplement or "gas station drug" despite being a prescription antidepressant in other countries. The bill establishes controls on tianeptine's sale, possession, and distribution within Delaware, treating it as a controlled substance or restricted product depending on the specific amendment language.
Tianeptine has gained popularity in the United States as an unregulated over-the-counter product marketed under names like "Za Za Red" and "Tianna," despite evidence of abuse potential and withdrawal symptoms similar to opioids. Delaware's action addresses a emerging public health concern by removing a substance from legal commerce that poses risks of dependency and adverse health effects, particularly among younger consumers seeking alternative highs.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
